GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: selection of NN2211 for clinical development

Research output: Contribution to journalJournal articleResearchpeer-review

L.B. Knudsen, H. Agerso, C. Bjenning, J.J. Holst

Original languageEnglish
JournalDrug Future
Issue number26
Pages (from-to)677-685
Publication statusPublished - 2001

ID: 170825